Prilosec OTC Soothes P&G First Quarter Forecast As Early Shipments Rollout
This article was originally published in The Tan Sheet
Executive Summary
Stronger than expected initial orders for Prilosec OTC are responsible in part for Procter & Gamble's increase in its first quarter earnings guidance for fiscal year 2004
You may also be interested in...
GSK, Galpharm Pioneer UK Nonprescription Omeprazole Market
Galpharm Healthcare will launch a nonprescription omeprazole product under the name Galpharm Heartburn Relief in the UK "shortly," according to a spokesperson for the British firm
GSK, Galpharm Pioneer UK Nonprescription Omeprazole Market
Galpharm Healthcare will launch a nonprescription omeprazole product under the name Galpharm Heartburn Relief in the UK "shortly," according to a spokesperson for the British firm
GSK, Galpharm Pioneer UK Nonprescription Omeprazole Market
Galpharm Healthcare will launch a nonprescription omeprazole product under the name Galpharm Heartburn Relief in the UK "shortly," according to a spokesperson for the British firm